THERAKIND

THERAKIND is a specialized pharmaceutical company focused on developing niche markets, dedicated to finding the right treatment solutions for all patients. It concentrates on developing niche drugs for hard-to-treat markets, including pediatric and elderly patient populations. Jylamvo is the company's orally administered methotrexate solution approved in Europe for the treatment of rheumatism, dermatological conditions, and acute lymphoblastic leukemia, and may also be suitable for adults.